VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways

Ling Zhou; Wei Ma; Zhen Yang; F Zhang; L Lu; Zhengnian Ding; Bo Ding; Tuanzhu Ha; Xiang Gao; C Li

doi:10.1038/sj.gt.3302416

VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways

Ling Zhou(Nanjing Medical University), Wei Ma(Nanjing Medical University), Zhen Yang(Nanjing Medical University), F Zhang(Nanjing Medical University), L Lu(Nanjing Medical University), Zhengnian Ding(Nanjing Medical University), Bo Ding(Nanjing Medical University), Tuanzhu Ha(Nanjing Medical University), Xiang Gao(Nanjing Medical University), C Li(Nanjing Medical University)

Gene Therapy

October 28, 2004

10.1038/sj.gt.3302416

Cited by 71

Abstract

Related Papers

No related papers found

Powered by citation graph analysis